Pregnancy Clinical Trial
Official title:
Pregnancy and Physical Activity: Text-message Referral to Evidence-based Websites
Fewer pregnant women achieve recommendations for physical activity (PA) (30 minutes of
moderate PA 5 days of the week) as compared to non-pregnant women (15.8% to 26.1%
respectively), and PA participation declines as pregnancy progresses. The benefits of PA
during pregnancy are abundant to both the mother (e.g., reduced weight gain, lower risk of
gestational diabetes) and the fetus (e.g., decreased fat mass, improved stress tolerance).
Pregnancy represents a significant time in a woman's life in which she may be motivated to
change her health behaviors due to concerns for the healthy development of the fetus and a
quick return to pre-pregnancy weight. Hence, pregnancy represents a critical time to support
women in PA participation.
In our previous research, 94% of pregnant and postpartum women of varying socioeconomic
statuses reported using the Internet for pregnancy and PA information. Despite some women
increasing their PA participation as a result, most did not know if a website was reputable
or reliable (i.e. evidence-based). Studies have reported that most online health information
is unregulated and inaccurate. Further, women often receive inadequate PA information from
physicians who are constrained by time and lack of knowledge about PA. Therefore, directing
pregnant women to evidence-based websites via text messaging may provide a feasible approach
to improve PA participation. PA participation in pregnant women is an ongoing challenge that
warrants testing of innovative solutions.
The purpose of this study is to determine the feasibility of using mobile phone text
messaging to refer pregnant women to evidence-based websites for PA information to increase
PA levels.
During Phase 1, the investigators will identify and test evidence-based websites and text
messages with our target population.
First the investigators will conduct interviews with pregnant women who meet physical
activity recommendations (n=15-20) (30 minutes of moderate intensity activity at least five
days per week) to ask them about what helps them to be active during their pregnancy. Using
the information gathered from these interviews and the literature the investigators will
develop text messages and 200-300 word mobile (i.e., cell phone, tablet computer) websites.
The mobile websites will include content from evidence-based websites, but will be adapted
for the mobile platform to enhance the user interface and readability of the websites. The
goal of the mobile websites is to allow women to access the websites by clicking on the link
in each text message. Once developed, the first draft of evidence-based websites and text
messages will be tested with interviews (pregnant women n=12, physician n=12, nurses/staff
n=12) prior to their use. All phase one participants will be recruited through word of mouth,
community nurse clinics and physician offices. Consultant Link will direct efforts to recruit
participants from community nurse clinics. Dr. Coonrod, Dr. Huls and Ms. Braescu will direct
efforts to recruit participants from physician offices. The purpose of the interviews are to
determine the feasibility (perceived acceptability and demand) and the appropriateness
(culturally and linguistically) of the material. A moderator and note-taker (student
researchers) trained by the PI (Huberty) and Co-I (Hekler) will conduct interviews. All
participants will receive $25 for their participation. The interviews will inform the second
draft of evidence-based websites and text messages, which will be used to implement the
intervention. An amendment that requests the approval of the text messages and websites will
be submitted after the completion of Phase 1 and prior to the commencement of Phase 2.
Addition to Phase 2 - The investigators will conduct a survey to determine the appropriate
dose (frequency and intensity) of physical activity text messages for Phase 2. The
investigators will use this information to determine how often during the pregnancy (e.g.,
daily, weekly) and when during the pregnancy (e.g., first, second, third trimester, or
throughout) that text messages with physical activity information are necessary to help women
participate in physical activity during their pregnancy. The survey is approximately 45
questions in length and takes about 5 minutes to complete. Pregnant women will be recruited
using word of mouth, fliers in places where pregnant women may be present (e.g., baby stores,
maternity stores, community nurse clinics and physician offices,), email list servs (e.g.
partnerships with Text 4 Baby and foundations related to pregnancy), and social media (e.g.,
Facebook, twitter). The investigators will recruit 200 women to complete the survey.
During Phase 2, the investigators will recruit women (n=75-100) to receive text messages
referring them to evidence-based websites for PA information. Flyers will be available in
physicians' clinics for posting and/or handout to women attending their first visit (8-16
weeks gestation). The PI will present the study information to physicians, nurses, and staff
at all physicians' sites; however, physicians, nurses, and staff will only participate in
passive recruitment methods via the study flyer. Participants will also be recruited
nationally using social media (i.e., Facebook, Twitter) and word of mouth (i.e., emails).
Interested participants will contact the research team (contact information on the flyer) to
learn more about the study and complete the eligibility questionnaire. After completing the
eligibility questionnaire (see attached), participants will be contacted via email to set up
a time to complete an intake appointment. Intake appointments (to review and sign the
informed consent form, discuss the study in more detail) with participants will take place
over the phone. The participants' informed consent and baseline questionnaires must be
received before they will be eligible to begin the intervention.
Participants will be assigned to a control group (n=25) or one of two intervention groups
(n=50). The control group will receive three standard Text4Baby messages per week.
Intervention group 1 will receive two physical activity messages and one standard Text4Baby
message each week. Intervention group 2 will receive six physical activity messages and one
standard Text4Baby message per week. The physical activity text message will refer the
participant to an evidence-based (HON Code certified) website that includes PA information
relative to the time in their pregnancy. Text messages will be pulled from a list of 150
possible text messages. The text messages and websites will provide educational information
about PA and its health benefits, but women will not be given a prescribed PA program to
follow as a part of this study. Therefore, a doctor's note approving women's participation in
this study is not necessary.
All Phase 2 participants will be objectively measured for physical activity using the Fitbit
activity monitor. The device will be mailed to women after completing the intake appointment
and returning the informed consent and baseline questionnaires. The women will wear the
device for 24 hours daily and will be asked to sync their device to their computer in order
to send researchers their physical activity feedback. All Fitbit monitors will be identified
only by a participant code to maintain the confidentiality of data when participants send
their data via wireless internet and when researchers receive the data. Women will also be
asked to complete short satisfaction surveys about some of the text messages. Fifteen women
will receive the satisfaction surveys once per week, and 60 women will receive the surveys
twice per month. The satisfaction survey is included with this application.
After the intervention, Phase 2 participants will be invited to participate in a voluntary
interview to further examine the feasibility of the intervention. Areas of focus will
include: acceptability (satisfaction, intention to use, perceived appropriateness), demand
(actual use, intention to use), and implementation (factors affecting ease or difficulty) of
using text messaging for referral to evidence-based websites for PA information. The
interview can be conducted in person or over the phone. Participants who complete the
intervention will be able to retain the FitBit device for their personal use.
Following the interview, participants will be invited to participate in Phase 3 of the study
(Part 2) (new consent form).
During Phase 3 (Part 2), the information collected on the Fitbit physical activity monitor
and synced with the user ID will be recorded during the mother's first year post-partum (from
time of birth until the child's first birthday) just as it was during the pregnancy. The
investigators will also send a survey, via a Qualtrics link, to complete every three months
(4 times total) during this first year post-partum. The survey will ask questions related to
mental health (i.e., stress, anxiety), physical health (i.e., weight, physical activity
participation), and psychosocial characteristics (i.e., mood, support).
All Phase 3 (Part 2) participants will complete a new informed consent document in which they
are aware that the investigators will continue to monitor their physical activity (without
text messages) and will complete 4 surveys.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |